MSB 4.69% $1.45 mesoblast limited

well on track , page-11

  1. 1,621 Posts.
    lightbulb Created with Sketch. 18
    I liked this bit myself...

    The applications of MPCs are remarkably broad, with treatments for cardiovascular disease, orthopaedics, diabetes, cancer and eye disease. In orthopaedics, for example, Mesoblast has shown that a small injection of MPCs into the site of discs damaged by degenerative intervertebral disc disease can result in the repair and regrowth of cartilage, reversing some of the serious effects of the disease, including lower back pain.

    The US market for this treatment alone was worth upwards of US$19 billion in 2008.

 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.